Case Study: a London-based therapeutics company accelerates proteomics research with Elucidata's Polly

a London-based therapeutics company accelerates proteomics research 24x with Elucidata

A London-based therapeutics company faced a significant challenge in accelerating its drug discovery research. The company struggled to find relevant and usable proteomics datasets from the PRIDE repository, as only about 25% of them were completely annotated. To overcome this, they partnered with Elucidata to access high-quality, machine-learning-ready data.

Elucidata employed a three-step approach to deliver 60 completely annotated, high-quality proteomics datasets that aligned with the company's specific criteria. Using Elucidata’s Polly Verified datasets, the company was able to kickstart its research in just one month instead of an estimated 24 months. This acceleration saved the customer over half a million dollars, demonstrating a significant measurable impact from Elucidata's solution.